Antibiotikaprofylax vid kirurgiska ingrepp - SBU

14. Kadurugamuwa JL, Beveridge TJ.
Natural release of virulence factors in
membrane vesicles by Pseudomonas
aeruginosa and the effect of aminoglycoside
antibiotics on their release.
J Antimicrob Chemother 1997;40:
615-21.
15. Leyh RG, Bartels C, Sievers HH.
Adjuvant treatment of deep sternal
wound infection with collagenous gentamycin.
Ann Thorac Surg 1999;68:
1648-51.
16. Ipsen T, Jorgensen PS, Damholt V,
Torholm C. Gentamicin-collagen sponge
for local applications. 10 cases of chronic
osteomyelitis followed for 1 year. Acta
Orthop Scand 1991;62:592-4.
17. Stemberger A, Grimm H, Bader F,
Rahn HD, Ascherl R. Local treatment
of bone and soft tissue infections with
the collagen-gentamicin sponge. Eur J
Surg Suppl 1997;17-26.
18. Vander Salm TJ, Okike ON, Pasque
MK, Pezzella AT, Lew R, Traina V,
Mathieu R. Reduction of sternal infection
by application of topical vancomycin.
J Thorac Cardiovasc Surg 1989;98:
618-22.
19. Tammelin A, Domicel P, Hambraeus A,
Stahle E. Dispersal of methicillin-resistant
Staphylococcus epidermidis by staff in an
operating suite for thoracic and cardiovascular
surgery: relation to skin carriage and
clothing. J Hosp Infect 2000;44:119-26.
20. Tammelin A, Hambraeus A, Stahle E.
Source and route of methicillin-resistant
Staphylococcus epidermidis transmitted to
the surgical wound during cardio-thoracic
surgery. Possibility of preventing wound
contamination by use of special scrub
suits. J Hosp Infect 2001;47:266-76.
21. Rosenthal VD, Maki DG, Graves N.
The International Nosocomial Infection
Control Consortium (INICC): goals
and objectives, description of surveillance
methods, and operational activities. Am J
Infect Control 2008;36:e1-12.
22. Townsend TR, Reitz BA, Bilker WB,
Bartlett JG. Clinical trial of cefamandole,
cefazolin, and cefuroxime for antibiotic
prophylaxis in cardiac operations. J Thorac
Cardiovasc Surg 1993;106:664-70.
23. Wilson AP, Gruneberg RN, Treasure
T, Sturridge MF. A clinical trial of teicoplanin
compared with a combination of
flucloxacillin and tobramycin as antibiotic
prophylaxis for cardiac surgery: the use of
a scoring method to assess the incidence
of wound infection. J Hosp Infect 1986;7
Suppl A:105-12.
24. Hall JC, Christiansen K, Carter MJ,
Edwards MG, Hodge AJ, Newman MA,
et al. Antibiotic prophylaxis in cardiac
operations. Ann Thorac Surg 1993;56:
916-22.
25. Bolon MK, Morlote M, Weber SG,
Koplan B, Carmeli Y, Wright SB. Glycopeptides
are no more effective than betalactam
agents for prevention of surgical
site infection after cardiac surgery: a metaanalysis.
Clin Infect Dis 2004;38:1357-63.
26. Dhadwal K, Al-Ruzzeh S, Athanasiou
T, Choudhury M, Tekkis P, Vuddamalay
P, et al. Comparison of clinical and economic
outcomes of two antibiotic prophylaxis
regimens for sternal wound infection
in high-risk patients following coronary
artery bypass grafting surgery: a prospec-
KAPITEL 4 • den systematiska litteraturöversikten
395